Dyslipidaemias are alterations to the plasma lipid profile that are often associated with
clinical conditions. Dyslipidaemias, particularly elevated plasma LDL-cholesterol levels, are …

Cardiovascular disease (CVD) is the leading cause of death in Asia. To combat the harmful
impacts of CVD on public health in Asian countries with more effective strategies and …

Background Hypertension can be detected at the primary health-care level and low-cost
treatments can effectively control hypertension. We aimed to measure the prevalence of …

Abstract Purpose of Review Obesity is a chronic disease, a major public health problem due
to its association with non-communicable diseases and all-cause mortality. Indeed, people …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

Abstract In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all
deaths in rural and urban areas, respectively. Two out of every five deaths were due to CVD …

Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial
infarction, stroke and peripheral arterial disease continue to be major causes of premature …

With rapid economic growth and changes at all levels (including environmental, social,
individual), China is facing a cardiovascular disease (CVD) crisis. In China, more than 40 …

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban
and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a …

There are 22 countries in the Eastern Mediterranean Region (EMR) expanding from
Morocco in the west to Pakistan and Afghanistan in the east, containing a population of …